Press release
Gestational Diabetes Market Trends Support A 8.7% CAGR Outlook Through The Forecast Period
Gestational Diabetes Market
Projected Market Growth and Size of the Gestational Diabetes Market
The gestational diabetes market is forecasted to experience robust growth, reaching a valuation of $13.85 billion by 2030. This represents a compound annual growth rate (CAGR) of 8.7% during the forecast period. Factors fueling this expansion include the rising prevalence of gestational diabetes worldwide, greater adoption of digital health monitoring technologies, advancements in prenatal diagnostic tools, a growing emphasis on preventive care for expecting mothers, and supportive healthcare policies. Important trends shaping the market involve increased use of blood glucose monitoring devices, expanded insulin therapy during pregnancy, a heightened focus on lifestyle management of the disease, broader implementation of prenatal screening programs, and enhanced awareness about maternal health.
The gestational diabetes market size has grown strongly in recent years. It will grow from $9.11 billion in 2025 to $9.93 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increasing obesity rates, higher maternal age pregnancies, early diabetes screening programs, growth in prenatal care services, awareness of pregnancy complications.
Download a free sample of the gestational diabetes market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20818&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Key Industry Players Driving the Gestational Diabetes Market
Several prominent companies are actively competing and innovating within the gestational diabetes market. These include well-known names such as Sanofi S.A., Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton dic*kinson and Company, Dexcom Inc, Biocon Limited, Ascensia Diabetes Care Holdings AG, Roche Diabetes Care, Medtronic plc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed Holding AG, Beta Bionics Inc, Bigfoot Biomedical Inc, Glooko Inc, Philips Healthcare, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd, Pfizer Inc, Novartis AG, Adocia SA, and Daiichi Sankyo Company Ltd.
Strategic Collaborations Enhancing Market Reach
In April 2024, Digostics, a UK-based provider specializing in home diabetes testing, entered into a partnership with AgaMatrix Europe to promote gestational diabetes screening. This collaboration grants AgaMatrix the exclusive rights to distribute Digostics' home oral glucose tolerance test (OGTT) service, GTT@home, to the UK National Health Service (NHS). Leveraging AgaMatrix's established network and expertise in gestational diabetes monitoring within NHS maternity services, this deal aims to accelerate the availability and adoption of home-based screening tools across the UK. AgaMatrix Europe itself is recognized for producing blood glucose monitoring solutions.
View the full gestational diabetes market report:
https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Technological Innovations Shaping Market Trends
Focusing on technological advancements, leading companies are developing sophisticated diagnostic products to enable accurate and timely detection of gestational diabetes. Diagnostic kits play a crucial role in measuring blood glucose levels and identifying abnormal glucose tolerance in pregnant women, facilitating early intervention and better disease management. For example, in August 2024, Austria-based biotechnology firm DirectSens GmbH introduced the XpressGT RUO kit. This diagnostic tool is designed not only for gestational diabetes but also for conditions like endometriosis, insulin resistance, and liver disease. It measures levels of 2-hydroxybutyrate (2-HB) in venous blood-a biomarker linked to endocrine and obesity-related disorders-using any standard clinical analyzer and delivers results within 8 minutes. This fast and reliable testing method offers significant benefits for clinical settings.
Detailed Segmentation of the Gestational Diabetes Market
This market is divided into several segments based on type, treatment, administration method, and end-use settings. By type, the market includes Type A1, Type A2, and other classifications. Type A1 covers diet-controlled and exercise-controlled gestational diabetes, whereas Type A2 includes insulin-controlled and oral medication-controlled cases. Other types consist of pre-gestational diabetes and gestational diabetes with complications.
In terms of treatment, the market breaks down into monitoring, drug treatment, and non-pharmacological approaches. Administration routes consist of oral, intravenous, and other methods. Lastly, end users for these products and services range across hospitals, clinics, home care environments, and diagnostic centers, reflecting a broad spectrum of healthcare delivery points.
New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gestational Diabetes Market Trends Support A 8.7% CAGR Outlook Through The Forecast Period here
News-ID: 4607697 • Views: …
More Releases from The Business Research Company
Hashimotos Disease Market Research Reveals Path To $2.27 Billion By 2030
The Hashimoto's Disease market is gaining increased attention as awareness about autoimmune thyroid conditions grows. With advancements in medical research and digital health technologies, this sector is poised for steady expansion in the coming years. Let's explore the market's projected growth, key players, and important segments shaping its future.
Forecasted Growth and Market Size for Hashimoto's Disease
The Hashimoto's disease market is projected to experience substantial growth, reaching a valuation…
Hair Restoration Market Demonstrates Long-Term Growth Potential At 11.9% CAGR
The hair restoration industry is on the brink of significant expansion as demand for innovative treatments and advanced technologies continues to rise. With a growing focus on regenerative medicine and minimally invasive procedures, this market is set to evolve rapidly over the coming years. Let's explore the current market size, key players, trends, and segmentation that are shaping the future of hair restoration.
Projected Growth and Market Size of the Hair…
Hair Drug Testing Market Outlook Signals Expansion To $3.4 Billion Through 2030
The hair drug testing sector is on the verge of remarkable expansion, driven by technological advancements and increasing demand across various industries. As concerns about workplace safety and compliance intensify, the market is responding with innovative solutions that promise greater accuracy and efficiency. Below, we explore the market's anticipated size, key players, prevailing trends, and segmentation details shaping this evolving landscape.
Anticipated Growth and Market Size of the Hair Drug Testing…
Gynecology Robotic Surgery Market Report 2026 Market Outlook Supported By A Fore …
The gynecology robotic surgery market is on track for significant expansion over the coming years, driven by technological advances and shifting clinical practices. As surgical robotics becomes increasingly sophisticated and widely adopted, the landscape of gynecological care is evolving toward less invasive and more precise procedures. The following sections explore the market's size, key players, emerging trends, and segmentation in detail.
Projected Market Growth and Future Outlook for Gynecology Robotic Surgery…
More Releases for Diabetes
Diabetes Software Market Revolution: Advancing Intelligent Digital Diabetes Care
The global Diabetes Software Market is witnessing significant transformation as healthcare systems increasingly embrace digital technologies to improve chronic disease management and patient outcomes. The growing need for continuous glucose monitoring, remote patient engagement, and data-driven clinical decision-making has accelerated the adoption of advanced diabetes software solutions across hospitals, clinics, and home care settings. These platforms are helping healthcare providers streamline treatment workflows while enabling patients to actively participate in…
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
